跳至主要内容
临床试验/NCT05341687
NCT05341687已完成不适用

Prognostic Value of Respiratory System Compliance Under VV-ECMO on 180-day Mortality in Patients With COVID-19 Associated Acute Respiratory Distress Syndrome (CARDS)

Central Hospital, Nancy, France1 个研究点 分布在 1 个国家目标入组 122 人开始时间: 2020年1月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
122
试验地点
1
主要终点
Vital status (dead or alive)

研究概览

简要总结

Mortality of patients with COVID-19 associated acute respiratory distress syndrome (CARDS) treated with veno-venous extra-corporal membrane oxygenation (vv-ECMO) is increasing over time since the beginning of the COVID-19 pandemic. The objectives were to retrospectively describe over the first ten days after vv-ECMO implantation, the ventilatory management of CARDS and to assess the impact of static respiratory system compliance (CRS) on the first day of vv-ECMO on 180-day mortality.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with ARDS secondary to COVID-19 pneumonia requiring ECMO-VV support, hospitalized in the intensive care units of the CHRU of Nancy, Marseille or Bordeaux between 01/03/2020 and 31/12/
  • Age > 18 years old

排除标准

  • Respiratory parameters not available on ten first day of VV ECMO implantation.
  • Patient refusal to participate in the study

结局指标

主要结局

Vital status (dead or alive)

时间窗: Days, 10.

according to compliance during the first ten days of VV ECMO implantation

次要结局

  • Evolution of driving pressure(Days, 10)
  • Evolution of PEEP(days, 10)
  • Evolution of tidal volume(Days, 10)

研究者

发起方
Central Hospital, Nancy, France
申办方类型
Other
责任方
Principal Investigator
主要研究者

Matthieu KOSZUTSKI

Principal investigator

Central Hospital, Nancy, France

研究点 (1)

Loading locations...

相似试验